Sequential Treatment with FLAG-IDA Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapse/Refractory or Adverse-Risk Leukemia

被引：1
|
作者：
Wolach, Ofir [1 ]
Shargian-Alon, Liat [1 ]
Raanani, Pia [1 ]
Yeshurun, Moshe [1 ]
机构：
[1] Rabin Med Ctr, Davidoff Canc Ctr, Hematol Inst, Petah Tiqwa, Israel
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-136
引用
收藏
页码：S284 / S285
页数：2
相关论文
共 50 条
  • [21] Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia
    刘微
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (03) : 186 - 186
  • [22] MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study
    Cao, Yang
    Huo, Wenxuan
    Huang, Jiayu
    Yang, Yang
    Wang, Yu
    Chang, Yingjun
    Wang, Luxiang
    Zhang, Zilu
    Jiang, Chuanhe
    Hu, Xiaoxia
    Mo, Xiaodong
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [23] MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study
    Cao, Yang
    Huo, Wenxuan
    Yang, Yang
    Huang, Jiayu
    Wang, Yu
    Huang, Liang
    Chang, Yingjun
    Hu, Xiaoxia
    Mo, Xiaodong
    BLOOD, 2023, 142
  • [24] MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study
    Yang Cao
    Wenxuan Huo
    Jiayu Huang
    Yang Yang
    Yu Wang
    Yingjun Chang
    Luxiang Wang
    Zilu Zhang
    Chuanhe Jiang
    Xiaoxia Hu
    Xiaodong Mo
    Blood Cancer Journal, 14
  • [25] Sequential chemotherapy followed by reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukemia (AML): a survey from the Acute Leukemia Working Party of EBMT
    Ringden, O.
    Labopin, M.
    Schmid, C.
    Sadeghi, B.
    Polge, E.
    Tischer, J.
    Ganser, A.
    Michallet, M.
    Kanz, L.
    Schwerdtfeger, R.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S476 - S477
  • [26] DECITABINE TREATMENT FOR ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Liu, X-L.
    Zhao, X.
    Wang, C.
    Gao, S-J.
    Tan, Y-H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (01): : 171 - 175
  • [27] Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
    Chen, Runzhe
    Campbell, Jos L.
    Chen, Baoan
    ONCOTARGETS AND THERAPY, 2015, 8 : 405 - 412
  • [28] Treatment of relapsed and refractory acute myeloid leukemia with a salvage FLAG-IDA chemotherapy regimen followed by a HLA matched related allogeneic PBSC infusion without additional conditioning
    Chandy, Mammen
    Mathews, Vikram
    Rajeskar, T.
    Viswabandya, Auro
    Lakshmi, Kavitha M.
    John, Joseph M.
    George, Biju
    Srivastava, Alok
    BLOOD, 2007, 110 (11) : 342B - 342B
  • [29] Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia
    Talbot, Alexis
    de Latour, Regis Peffault
    Raffoux, Emmanuel
    Buchbinder, Nimrod
    Vigouroux, Stephane
    Milpied, Noel
    Leblanc, Thierry
    Soulier, Jean
    Michallet, Mauricette
    Socie, Gerard
    HAEMATOLOGICA, 2014, 99 (10) : E199 - E200
  • [30] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    María P. Martínez Sánchez
    Juan Eduardo Megías-Vericat
    Rebeca Rodríguez-Veiga
    Susana Vives
    Juan Miguel Bergua
    Anna Torrent
    Sara Suárez-Varela
    Blanca Boluda
    Joaquín Martínez-López
    Isabel Cano-Ferri
    Evelyn Acuña-Cruz
    Laura Torres-Miñana
    Beatriz Martín-Herreros
    Alfons Serrano
    Amparo Sempere
    Eva Barragán
    Claudia Sargas
    Miguel Sanz
    David Martínez-Cuadrón
    Pau Montesinos
    Annals of Hematology, 2021, 100 : 1497 - 1508
12345